A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China
NCT05388916
·
clinicaltrials.gov ↗
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Moderate to Severe Chronic Plaque Psoriasis
Interventions
OTHER:
Cosentyx
Sponsor
Novartis Pharmaceuticals